Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Asston Pharmaceuticals announced its 2nd EGM for FY 2026-27 will be held on July 31, 2026, via video conferencing. Remote e-voting for members will be available from July 28 to July 30, with July 24 as the cut-off date.
Jul 10 2026 17:36:54
Asston Pharmaceuticals Ltd - 544445 - Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 12:30 PM
Asston Pharmaceuticals will hold an Extraordinary General Meeting (EGM) on July 31, 2026, to consider and approve a preferential issue of equity shares. The company proposes to raise Rs.27.72 crore by issuing 2.41 million shares at Rs.115 each, with proceeds earmarked for working capital, debt repayment, and capital expenditure.
Jul 09 2026 16:48:47
Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Meeting Updates
Asston Pharmaceuticals' board has approved a preferential issue of up to 24.10 lakh equity shares to non-promoter category investors. This fundraise, valued at Rs.27.72 crore at an issue price of Rs.115 per share, is subject to shareholder and regulatory approvals.
Jul 02 2026 18:47:01
Asston Pharmaceuticals Ltd - 544445 - Announcement Regarding Extraordinary General Meeting Of The Company.
Asston Pharmaceuticals board approved a preferential issue of up to 2.41 million equity shares at Rs.115 per share, aggregating Rs.27.72 crore. The issue is to non-promoter entities for cash and requires shareholder approval at an EGM to be held on July 31, 2026.
Jul 02 2026 18:42:27
Asston Pharmaceuticals Ltd - 544445 - Update On Board Meeting Scheduled To Be Held On 02Nd July, 2026.
Asston Pharma's board has approved a preferential issue of 2.41 million equity shares at Rs.115 per share, totaling Rs.27.72 crore. This fundraise is from non-promoter entities and requires shareholder approval at an upcoming EGM on July 31, 2026.
Jul 02 2026 18:35:45
Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Preferential Issue
Asston Pharmaceuticals board approved a preferential issue of up to 24.10 lakh equity shares at Rs.115 per share, aggregating Rs.27.72 crore. This fundraise is to non-promoter entities and requires shareholder approval via an EGM.
Jul 02 2026 18:26:49
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July, 2026.
Asston Pharmaceuticals board approved a preferential issue of up to 24.10 lakh equity shares at ₹115 per share, aggregating to ₹27.72 crores. This issue is to non-promoters on a preferential basis and requires shareholder approval at an EGM on July 31, 2026.
Jul 02 2026 18:22:20
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Board Meeting Intimation
Asston Pharmaceuticals will hold a board meeting on July 02, 2026. The agenda includes considering proposals for fundraising through various methods, such as a preferential issue, pending necessary approvals.
Jun 24 2026 18:41:14
Read More